Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000068
Filing Date
2024-10-01
Accepted
2024-09-30 21:32:13
Documents
11
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 6-K a2024-10x01convertiblenote.htm 6-K 21944
2 EX-99.1 exhibit991.htm EX-99.1 10719
3 EX-99.2 exhibit992.htm EX-99.2 1712
4 exhibit991001.jpg GRAPHIC 245971
5 exhibit991002.jpg GRAPHIC 320127
6 exhibit991003.jpg GRAPHIC 84951
7 exhibit992001.jpg GRAPHIC 75526
8 exhibit992002.jpg GRAPHIC 106052
9 exhibit992003.jpg GRAPHIC 137819
10 exhibit992004.jpg GRAPHIC 162207
11 exhibit992005.jpg GRAPHIC 95077
  Complete submission text file 0001345099-24-000068.txt   1726838
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 241341037
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)